文献速递产科母胎医学

剖宫产术后母亲抑郁与阿片类药物使用的关系

Maternal Depression and Opioid Use After Cesarean Delivery.
PubMed 文献 · Obstet Gynecol · 2026-03-19

本研究为多中心随机试验的二次分析,纳入2020至2022年美国12家医院剖宫产者5504例,评估自报抑郁史及治疗状态与术后阿片使用的关系。结果显示抑郁史不论治疗与否均不与住院期间阿片用量增加相关,但未治疗抑郁与产后6周内门诊阿片用量增加及感知疼痛干扰更高相关。

要点

  • 抑郁史不增加剖宫产后住院期间阿片用量。
  • 未治疗抑郁与产后6周门诊阿片用量增加相关。
  • 抑郁史与日常活动疼痛干扰增加相关,无论治疗与否。

核心结论

  • 自报抑郁史不论治疗状态均不与剖宫产后住院阿片用量增加相关,但未治疗抑郁与产后6周门诊阿片用量增加相关。

研究设计与样本

  • 多中心随机试验的二次分析,纳入2020至2022年美国12家医院剖宫产者5504例。

主要发现

  • 5504例中1507例(27.4%)有自报抑郁,其中663例(44.0%)接受治疗。
  • 抑郁组更常见慢性疼痛、吸烟和睡眠紊乱(P<.0001)。
  • 调整模型中,治疗或未治疗抑郁均不与住院期间每日口服阿片MME相关。
  • 未治疗抑郁与产后6周门诊阿片用量较高相关(调整中位差16.7 MMEs/d,95%CI 8.9-24.5),并与出院1周中重度感知疼痛较高相关。
  • 治疗抑郁和未治疗抑郁均与日常活动疼痛干扰较高相关(调整OR分别为1.44,95%CI 1.2-1.8和1.37,95%CI 1.1-1.7)。

关键数值与推荐

  • 主要结局为剖宫产术后12小时至出院每日口服阿片用量(MME)。
  • 次要结局包括产后6周门诊阿片处方MME、出院1周BPI评分≥4的中重度疼痛和日常活动干扰。

临床怎么用

  • 对剖宫产者应识别未治疗抑郁,因其与产后6周门诊阿片用量增加及疼痛干扰较高相关。
  • 抑郁史本身不应作为增加住院阿片用量的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between self-reported history of maternal depression by treatment status and opioid use after cesarean delivery. METHODS: This was a secondary analysis of a multicenter randomized trial of individuals who underwent cesarean delivery at 12 U.S. hospitals from 2020 to 2022. We evaluated two exposures for patients with a self-reported history of depression assessed on the enrollment form: treatment (pharmacologic or nonpharmacologic therapy during pregnancy) or no treatment. The primary outcome was inpatient oral opioid use in morphine milligram equivalents (MMEs) per day from 12 hours after cesarean delivery through hospital discharge. Secondary outcomes included outpatient opioid use (MMEs of opioid prescriptions through 6 weeks postpartum) and moderate-to-severe perceived pain (score 4 or higher) and interference in daily activities (score 4 or higher) on a validated questionnaire, the BPI (Brief Pain Inventory, score 1-10) at 1 week after discharge. Multivariable modeling (quantile regression for continuous outcomes and logistic regression for binary outcomes) evaluated the association between untreated or treated depression compared with no depression and the selected outcomes. RESULTS: Of 5,504 study participants, 1,507 (27.4%) had self-reported depression, of whom 663 (44.0%) were treated. Those with depression were more likely to have a chronic pain condition (19.5% untreated, 18.9% treated, and 8.5% no depression, P <.0001), to use tobacco (22.5% untreated, 18.9% treated, and 8.1% no depression, P <.0001), and to experience disordered sleep (median score [IQR] 57.9 [52.8-63.7] for untreated, 59.3 [53.8-64.2] for treated, and 55.7 [50.3-60.6] for no depression, P <.0001). In adjusted modeling, neither treated nor untreated depression was associated with inpatient postpartum MMEs. However, untreated depression was associated with higher outpatient MME use through 6 weeks postpartum (adjusted median difference 16.7 MMEs/d [95% CI, 8.9-24.5]) and higher moderate-to-severe perceived pain at 1 week after discharge. Both treated depression and untreated depression were associated with higher perceived pain interference in daily activities (adjusted odds ratio 1.44 [95% CI, 1.2-1.8] and 1.37 [95% CI, 1.1-1.7], respectively). CONCLUSION: Self-reported history of depression, regardless of treatment status, was not associated with increased post-cesarean delivery inpatient opioid use, but untreated depression was associated with increased opioid use through 6 weeks postpartum.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pitt TL, Boekhoudt TM, Rood KM, et al. Maternal Depression and Opioid Use After Cesarean Delivery. Obstet Gynecol. 2026. PMID: 41855534. doi:10.1097/AOG.0000000000006248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。